Yeah, I know you're in a bind and I'm glad I'm not. Not that my sympathy counts for much, but it's there.
I can't see into the heart of the AFR editorial room, but Google searching a couple layers deep on the names and connections joining up with BIG through the new board announcements and it's not looking very clean to me. I suspect AFR are keeping the heat on because it looks similarly unsavoury to them.
I do think that there will be an value realisation point with this stock, though, and I would grab it when it comes. They will relist and they will continue operations outside of Aus. And if I were invested I would take the cash at the first chance it looked good in the next 18 months or so, making sure I never got greedy. Just got my cash and got out. That's my opinion, obviously, that the personal investment choice I would make in this company were I already invested. Other's mileage will vary.
- Forums
- ASX - By Stock
- BIG
- Ann: Company appointment of new Chairman
Ann: Company appointment of new Chairman, page-87
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online